Key result
The Hemopump, a miniature axial flow temporary left ventricular assist blood pump placed transvalvularly across the aortic valve, has met design challenges and shows potential as a safe clinical device.
Design
Other
Authors
Loading...
Supports percutaneous LVAD feasibility in acute settings; leaves open randomized efficacy trials before practice change.
The Hemopump represents a novel percutaneous temporary left ventricular assist device with promising early clinical potential.
Butler et al. (1990) reported a review. Hemopump was evaluated. The Hemopump, a miniature axial flow temporary left ventricular assist blood pump placed transvalvularly across the aortic valve, has met design challenges and shows potential as a safe clinical device.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: